GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.92B
Enterprise Value5.23B
P/E Ratio5,730.43
PEG Ratio-57.53
Price/Sales Ratio3.41
Price/Book Ratio3.64
Enterprise/Revenue3.67
Enterprise/EBITDA73.12

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue1.7B
Revenue/Share3.86
Gross Profit1.19B
EBITDA152.9M
Net Income46.25M
Diluted EPS0.11

Balance Sheet

Total Cash312.04M
Total Cash/Share0.77
Total Debt716.54M
Total Debt/Equity0.49
Current Ratio1.71
Book Value Per Share3.88

Price History

52-Week Change5.27
52-Week High17.46
52-Week Low9.51
Moving Average 50 Days12.2
Moving Average 200 Days12.29

Statistics

Average Volume16.19M
Shares Outstanding403.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.06
Trailing Annual Dividend Yield0.46
Payout Ratio88.21
Last Split FactorN/A
Last Split DateN/A
AD